Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Lilly's new 5-HT1D agonists claimed for CNS and bladder disorders

Jan. 4, 1999

OPC-31260: potential utility in cirrhosis patients with impaired water handling

Dec. 30, 1998

Tobishi's pollen extract improves bladder dysfunction, nonbacterial prostatitis in rats

Dec. 21, 1998

FDA clears first and only once-daily treatment for overactive bladder

Dec. 21, 1998

New agents for micturition disorders discovered at Kyowa Hakko

Dec. 16, 1998

Vanguard drops hyperphosphatemia Rx from development pipeline

Dec. 16, 1998

Fujisawa describes potential new agent for treating BPH

Dec. 8, 1998

Pharmacokinetic studies support chronic dosing of FK-143

Dec. 3, 1998

Health Canada approves first new incontinence medication in over a decade

Dec. 3, 1998

Tamsulosin improves signs and symptoms of BPH in phase III study

Dec. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...